{
    "article_link": "https://www.frontiersin.org/articles/10.3389/fonc.2023.1186858/full",
    "data": [
        {
            "id": "data_1",
            "omics": "Transcriptomics",
            "link": "https://xenabrowser.net/datapages/",
            "format": "RNA-seq Level-3",
            "source": "University of California Santa Cruz (UCSC)",
            "public_id": "TCGA-BRCA RNA-seq"
        },
        {
            "id": "data_2",
            "omics": "Genomics",
            "link": "https://xenabrowser.net/datapages/",
            "format": "CNV (GISTIC2)",
            "source": "University of California Santa Cruz (UCSC)",
            "public_id": "TCGA-BRCA CNV"
        },
        {
            "id": "data_3",
            "omics": "Epigenomics",
            "link": "https://xenabrowser.net/datapages/",
            "format": "DNA Methylation Array (450K)",
            "source": "University of California Santa Cruz (UCSC)",
            "public_id": "TCGA-BRCA DNA methylation"
        },
        {
            "id": "data_4",
            "omics": "Transcriptomics",
            "link": "http://www.ncbi.nlm.nih.gov/geo/",
            "format": "RNA-seq",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE7390"
        },
        {
            "id": "data_5",
            "omics": "Transcriptomics",
            "link": "http://www.ncbi.nlm.nih.gov/geo/",
            "format": "RNA-seq",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE20685"
        },
        {
            "id": "data_6",
            "omics": "Transcriptomics",
            "link": "http://www.ncbi.nlm.nih.gov/geo/",
            "format": "Single-cell RNA-seq",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE176078"
        },
        {
            "id": "data_7",
            "omics": "Transcriptomics",
            "link": "http://www.ncbi.nlm.nih.gov/geo/",
            "format": "RNA-seq",
            "source": "Gene Expression Omnibus (GEO)",
            "public_id": "GSE103091"
        }
    ],
    "analyses": [
        {
            "id": "analysis_1",
            "analysis_name": "Fisherâ€™s method-based hub gene screening",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_3"
            ],
            "label": null
        },
        {
            "id": "analysis_2",
            "analysis_name": "Construction and validation of RS signature",
            "analysis_data": [
                "data_1",
                "data_2",
                "data_3"
            ],
            "label": null
        },
        {
            "id": "analysis_3",
            "analysis_name": "Kaplan-Meier (KM) analysis",
            "analysis_data": [
                "analysis_2"
            ],
            "label": {
                "risk_group": [
                    "high-risk",
                    "low-risk"
                ]
            }
        },
        {
            "id": "analysis_4",
            "analysis_name": "Receiver Operating Characteristic (ROC) analysis",
            "analysis_data": [
                "analysis_2"
            ],
            "label": {
                "risk_group": [
                    "high-risk",
                    "low-risk"
                ]
            }
        },
        {
            "id": "analysis_5",
            "analysis_name": "Multivariate Cox regression and Nomogram analysis",
            "analysis_data": [
                "analysis_2"
            ],
            "label": {
                "clinical_factors": [
                    "age",
                    "T",
                    "N",
                    "M",
                    "TNM stage"
                ]
            }
        },
        {
            "id": "analysis_6",
            "analysis_name": "Stratification analysis by TNM stages",
            "analysis_data": [
                "analysis_2"
            ],
            "label": {
                "TNM_stage": [
                    "I/II",
                    "III/IV"
                ]
            }
        },
        {
            "id": "analysis_7",
            "analysis_name": "Stratification analysis by molecular subtypes",
            "analysis_data": [
                "analysis_2"
            ],
            "label": {
                "molecular_subtype": [
                    "ER-negative",
                    "ER-positive",
                    "PR-negative",
                    "PR-positive",
                    "HER2-negative",
                    "HER2-positive"
                ]
            }
        },
        {
            "id": "analysis_8",
            "analysis_name": "Stratification analysis in TNBC patients",
            "analysis_data": [
                "analysis_2",
                "data_6",
                "data_7"
            ],
            "label": {
                "molecular_subtype": [
                    "TNBC",
                    "non-TNBC"
                ],
                "dataset": [
                    "training_set",
                    "GSE103091"
                ]
            }
        },
        {
            "id": "analysis_9",
            "analysis_name": "Single-cell data analysis",
            "analysis_data": [
                "data_6"
            ],
            "label": {
                "risk_group": [
                    "high-risk",
                    "low-risk"
                ]
            }
        },
        {
            "id": "analysis_10",
            "analysis_name": "Immune checkpoint analysis",
            "analysis_data": [
                "analysis_2"
            ],
            "label": {
                "risk_group": [
                    "high-risk",
                    "low-risk"
                ]
            }
        },
        {
            "id": "analysis_11",
            "analysis_name": "Drug sensitivity analysis",
            "analysis_data": [
                "analysis_2",
                "data_7"
            ],
            "label": {
                "risk_group": [
                    "high-risk",
                    "low-risk"
                ]
            }
        }
    ],
    "results": [
        {
            "analysis_id": "analysis_3",
            "metrics": "p-value",
            "value": "<0.001",
            "features": null
        },
        {
            "analysis_id": "analysis_4",
            "metrics": "AUC",
            "value": "0.738 (3 years), 0.701 (5 years)",
            "features": null
        },
        {
            "analysis_id": "analysis_5",
            "metrics": "AUDC",
            "value": "0.008 (3 years), 0.023 (5 years)",
            "features": null
        },
        {
            "analysis_id": "analysis_6",
            "metrics": "p-value",
            "value": "<0.001 (I/II), 0.001 (III/IV)",
            "features": null
        },
        {
            "analysis_id": "analysis_7",
            "metrics": "p-value",
            "value": "0.002 (ER-negative), <0.001 (ER-positive), <0.001 (PR-negative), 0.033 (PR-positive), <0.001 (HER2-negative), 0.005 (HER2-positive)",
            "features": null
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "p-value",
            "value": "0.023 (training_set), 0.003 (GSE103091)",
            "features": null
        },
        {
            "analysis_id": "analysis_8",
            "metrics": "AUC",
            "value": "0.665 (3 years), 0.666 (5 years) in training_set; 0.719 (3 years), 0.713 (5 years) in GSE103091",
            "features": null
        },
        {
            "analysis_id": "analysis_9",
            "metrics": "Cellular composition difference",
            "value": "Overall cells and lymphocytes composition differ between high-risk and low-risk patients",
            "features": [
                "MSC",
                "B_cells",
                "T_cells"
            ]
        },
        {
            "analysis_id": "analysis_10",
            "metrics": "Expression difference",
            "value": "Down-regulated expressions of immune checkpoints in high-risk TNBC patients",
            "features": [
                "BTLA",
                "CD200R1",
                "CD27",
                "CD28",
                "CD40",
                "CD40LG",
                "CTLA4",
                "HLA-DRB1",
                "IL2RB",
                "LAG3",
                "PDCD1",
                "TIGIT",
                "TNFRSF14"
            ]
        },
        {
            "analysis_id": "analysis_11",
            "metrics": "IC50 difference",
            "value": "Lower sensitivity to most drugs in high-risk subgroup, except BI2536 (higher sensitivity in high-risk subgroup)",
            "features": [
                "BI2536",
                "Camptothecin",
                "Epirubicin",
                "Vinnorelbine"
            ]
        }
    ]
}